Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial-Reference-Cited by-同舟云学术

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

Published:2013-06 Issue:6 Volume:57 Page:2155-2163
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sulkowski Mark S.,Bourlière Marc,Bronowicki Jean-Pierre,Asselah Tarik,Pawlotsky Jean-Michel,Shafran Stephen D.,Pol Stanislas,Mauss Stefan,Larrey Dominique,Datsenko Yakov,Stern Jerry O.,Kukolj George,Scherer Joseph,Nehmiz Gerhard,Steinmann Gerhard G.,Böcher Wulf O.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26386/fullpdf

Reference15 articles.

1. Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy;Yoshida;Can J Gastroenterol,2009

2. Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial;Jensen;Ann Intern Med,2009

3. Boceprevir for previously treated chronic HCV genotype 1 infection;Bacon;N Engl J Med,2011

4. Telaprevir for retreatment of HCV infection;Zeuzem;N Engl J Med,2011

5. BI 201335 pharmacokinetics and early effect on viral load in HCV genotype-1 patients [Abstract 1249];Yong;J Hepatol,2011

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of itraconazole on the pharmacokinetics of faldaprevir in healthy subjects;PHARMAZIE;2021

2. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses;Current Medicinal Chemistry;2019-10-16

3. Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study;Basic & Clinical Pharmacology & Toxicology;2018-03-30

4. Direct-acting antivirals for chronic hepatitis C;Cochrane Database of Systematic Reviews;2017-09-18

5. Direct-acting antivirals for chronic hepatitis C;Cochrane Database of Systematic Reviews;2017-06-06